2349: Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients

Storey, R.F. orcid.org/0000-0002-6677-6229, Gurbel, P.A., James, S. et al. (12 more authors) (2019) 2349: Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients. In: EUROPEAN HEART JOURNAL. ESC Congress 2019 together with World Congress of Cardiology, 31 Aug - 04 Sep 2019, Paris, France. Oxford University Press , p. 1355.

Metadata

Authors/Creators:
  • Storey, R.F. ORCID logo https://orcid.org/0000-0002-6677-6229
  • Gurbel, P.A.
  • James, S.
  • Ten Berg, J.M.
  • Tanguay, J.-F.
  • Bernaud, C.
  • Frenoux, J.-M.
  • Hmissi, A.
  • Van Der Harst, P.
  • Van't Hof, A.W.J.
  • Dangas, G.D.
  • Kunadian, V.
  • Gorog, D.A.
  • Trenk, D.
  • Angiolillo, D.J.
Copyright, Publisher and Additional Information: © The Author(s) 2019
Dates:
  • Published (online): 21 October 2019
  • Published: October 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 27 Oct 2022 07:55
Last Modified: 27 Oct 2022 07:55
Status: Published
Publisher: Oxford University Press
Refereed: Yes
Identification Number: https://doi.org/10.1093/eurheartj/ehz748.0136
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)